Na Meng

Na Meng has extensive work experience in the biopharmaceutical industry and investment banking sector. Currently, they serve as the Executive Director of Strategy and Investment at I-Mab Biopharma. Prior to this, Na held the position of Director of Capital Markets and Strategy at Genor Biopharma. Na also worked at Deutsche Bank as a Research Analyst, focusing on the Asia Healthcare sector. Additionally, Na has experience in equity and debt capital markets, having worked as an Analyst at Bank of America Merrill Lynch in both APAC Equity Capital Markets and EMEA Debt Capital Markets. Na began their career at RBS as an Analyst in Global Markets.

Na MENG attended HEC Paris from 2013 to 2016, where they earned a Grande École degree. Prior to that, they completed a Bachelor of Arts degree at Fudan University from 2009 to 2013.